Showing results (181-190 of 286) with videos related to

Sort By:
Pageof 29
Frontiers in Oncology|April 11, 2022
Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall SurvivalStavroula A Paschou, Michael Liontos, Evangelos Eleftherakis-Papaiakovou, et al.
Journal of Environmental Management|August 21, 2022
Printing Ink Wastewater Treatment Using Hydrodynamic Cavitation and Coagulants/FlocculantsCharikleia Zampeta, Chrysanthi Paparouni, Andreas Tampakopoulos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 5, 2023
Pembrolizumab in combination with bevacizumab and oral cyclophosphamide in heavily pre-treated platinum-resistant ovarian cancerAngeliki Andrikopoulou, Michalis Liontos, Efthymia Skafida, et al.
Oncotargets and Therapy|October 25, 2017
Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanibKonstantinos Koutsoukos, Aristotelis Bamias, Kimon Tzannis, et al.
World Journal of Urology|September 28, 2015
Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG)Konstantinos Koutsoukos, Kimon Tzannis, Christos Christodoulou, et al.
Frontiers in Oncology|December 19, 2022
Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysisAngeliki Andrikopoulou, Eleni Zografos, Kleoniki Apostolidou, et al.
Critical Reviews in Oncology/Hematology|February 23, 2024
Cardiovascular complications of ribociclib in breast cancer patientsOraianthi Fiste, Evangelos Mavrothalassitis, Kleoniki Apostolidou, et al.
Statistics in Medicine|March 15, 1994
Discrimination techniques applied to the NCI in vitro anti-tumour drug screen: predicting biochemical mechanism of actionA D Koutsoukos, L V Rubinstein, D Faraggi, et al.
Journal of Clinical Periodontology|May 15, 2001
Prevalence and risk indicators for destructive periodontal diseases in 3 urban American minority populationsR G Craig, R Boylan, J Yip, et al.
Journal of Hematology & Oncology|June 1, 2021
Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitorsEvangelos Terpos, Flora Zagouri, Michalis Liontos, et al.
Pageof 29